Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9653881rdf:typepubmed:Citationlld:pubmed
pubmed-article:9653881lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9653881lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9653881lifeskim:mentionsumls-concept:C2936508lld:lifeskim
pubmed-article:9653881lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:9653881lifeskim:mentionsumls-concept:C1519355lld:lifeskim
pubmed-article:9653881lifeskim:mentionsumls-concept:C0527460lld:lifeskim
pubmed-article:9653881pubmed:issue2-3lld:pubmed
pubmed-article:9653881pubmed:dateCreated1998-9-17lld:pubmed
pubmed-article:9653881pubmed:abstractTextIn rat neocortical slices maintained in Mg2+-free Krebs medium, the GABAB receptor agonists baclofen and 3-aminopropylphosphinic acid dose-dependently reduced the frequency of spontaneous discharges, 3-aminopropylphosphinic acid being 10 times less potent than baclofen. These were sensitive to the antagonist CGP 52432 (3-[[3,4-dichloro-phenyl)methyl]-amino]propyl](-P-diethoxymethyl)- phosphinic acid) (1, 5 and 10 microM). The GABA uptake inhibitor NO-711 (1-(2-(((diphenylmethylene)amino)oxy)ethyl)-1,2,5,6-tetrahydro-3-+ ++pyridinecarboxylic acid) (5 and 10 microM) produced 2.9 and 9 fold increases in the potency of 3-aminopropylphosphinic acid without affecting baclofen-induced responses. In this study, the low potency of 3-aminopropylphosphinic acid when compared to baclofen, may be attributed to its uptake by NO-711-sensitive GABA transporters.lld:pubmed
pubmed-article:9653881pubmed:languageenglld:pubmed
pubmed-article:9653881pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:citationSubsetIMlld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9653881pubmed:statusMEDLINElld:pubmed
pubmed-article:9653881pubmed:monthAprlld:pubmed
pubmed-article:9653881pubmed:issn0014-2999lld:pubmed
pubmed-article:9653881pubmed:authorpubmed-author:KerrD IDIlld:pubmed
pubmed-article:9653881pubmed:authorpubmed-author:LIT KTKlld:pubmed
pubmed-article:9653881pubmed:issnTypePrintlld:pubmed
pubmed-article:9653881pubmed:day24lld:pubmed
pubmed-article:9653881pubmed:volume347lld:pubmed
pubmed-article:9653881pubmed:ownerNLMlld:pubmed
pubmed-article:9653881pubmed:authorsCompleteYlld:pubmed
pubmed-article:9653881pubmed:pagination197-200lld:pubmed
pubmed-article:9653881pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:meshHeadingpubmed-meshheading:9653881-...lld:pubmed
pubmed-article:9653881pubmed:year1998lld:pubmed
pubmed-article:9653881pubmed:articleTitleThe gamma-aminobutyric acid uptake inhibitor NO-711 potentiates 3-aminopropylphosphinic acid-induced actions in rat neocortical slices.lld:pubmed
pubmed-article:9653881pubmed:affiliationDepartment of Anaesthesia and Intensive Care, The University of Adelaide, South Australia, Australia. jong@medicine.adelaide.edu.aulld:pubmed
pubmed-article:9653881pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9653881pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9653881pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed